Search results for "Œdème maculaire OCT Diabète Occlusion veineuse Inflammation VEGF Corticoïdes"

showing 1 items of 1 documents

Treatment of macular oedema (excluding age-related macular degeneration (AMD))

2021

Macular oedema corresponds to an increase in macular thickness most often associated with a rupture of the hematoretinal barriers. Diagnosis is based on the notion of reduced vision, but above all on multimodal imaging in which optical coherence tomography (OCT) plays an essential role both for the initial diagnosis and for follow-up. The mechanisms involved in the occurrence of macular oedema are primarily vascular endothelial growth factor (VEGF) and cytokines regardless of the aetiology of the oedema. Treatment often involves a combination of local treatment - primarily intravitreal injections of anti-VEGF or corticosteroids - and, in certain situations, such as diabetes or uveitis, gene…

Inflammation[SDV.MHEP] Life Sciences [q-bio]/Human health and pathologyOCT[SDV.MHEP.OS] Life Sciences [q-bio]/Human health and pathology/Sensory OrgansDiabetesŒdème maculaire OCT Diabète Occlusion veineuse Inflammation VEGF CorticoïdesCorticoidsMacular oedemaVEGFVenous occlusion
researchProduct